ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison

Bibliography

• Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004;43:487-514
   PubMed Web of Science ®Google Scholar
• Mao Q. BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm Res 2008;25:1244-55
   PubMed Web of Science ®Google Scholar
• Myllynen P, Immonen E, Kummu M, Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol 2009;5:1483-99
   PubMed Web of Science ®Google Scholar
• Bliek BJ, van Schaik RH, van der Heiden IP, Eurocran Gene-Environment Interaction Group. Maternal medication use, carriership of the ABCB1 3435C > T polymorphism and the risk of a child with cleft lip with or without cleft palate. Am J Med Genet A 2009;149A:2088-92
   PubMed Web of Science ®Google Scholar
• Lankas GR, Wise LD, Cartwright ME, Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 1998;12:457-63
   PubMed Web of Science ®Google Scholar
• Vasilou V, Vasilou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Hum Genomics 2009;3:281-90
   PubMedGoogle Scholar
• Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010;62:1-96
   PubMed Web of Science ®Google Scholar
• International Transporter Consortium, Giacomini KM, Huang SM, Membrane transporters in drug development. Nat Rev Drug Discov 2010;9:215-36
   PubMed Web of Science ®Google Scholar
• Robey RW, To KK, Polgar O, ABCG2: a perspective. Adv Drug Deliv Rev 2009;61:3-13
   PubMed Web of Science ®Google Scholar
• Deeley RG, Westlake C, Cole SP. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 2006;86:849-99
   PubMed Web of Science ®Google Scholar
• Sarkadi B, Homolya L, Szakacs G, Varadi A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 2006;86:1179-236
   PubMed Web of Science ®Google Scholar
• Takano M, Yumoto R, Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol Ther 2006;109:137-61
   PubMed Web of Science ®Google Scholar
• Loscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005;6:591-602
   PubMed Web of Science ®Google Scholar
• Maliepaard M, Scheffer GL, Faneyte IF, Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001;61:3458-64
   PubMed Web of Science ®Google Scholar
• Doyle LA, Yang W, Abruzzo LV, A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 1998;95:15665-70
   PubMed Web of Science ®Google Scholar
• Li M, Yuan H, Li N, Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. Eur J Pharm Sci 2008;35:114-26
   PubMed Web of Science ®Google Scholar
• Warren MS, Zerangue N, Woodford K, Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol Res 2009;59:404-13
   PubMed Web of Science ®Google Scholar
• Choudhuri S, Klaassen CD. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 2006;25:231-59
   PubMed Web of Science ®Google Scholar
• Macdonald N, Gledhill A. Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans. Arch Toxicol 2007;81:553-63
   PubMed Web of Science ®Google Scholar
• Faber JJ, Thornburg KL, Binder ND. Physiology of placental transfer in mammals. Am Zool 1992;32:343-54
   Google Scholar
• Leiser R, Kaufmann P. Placental structure: in a comparative aspect. Exp Clin Endocrinol 1994;102:122-34
   PubMedGoogle Scholar
• Page K. The physiology of the human placenta. UCL Press Limited, London; 1993
   Google Scholar
• Enders AC, Blankenship TN. Comparative placental structure. Adv Drug Deliv Rev 1999;38:3-15
   PubMed Web of Science ®Google Scholar
• Jones CJ, Fox H. Ultrastructure of the normal human placenta. Electron Microsc Rev 1991;4:129-78
   PubMedGoogle Scholar
• Sugawara I, Kataoka I, Morishita Y, Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988;48:1926-9
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien JP, Boccia J, Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277-87
   PubMed Web of Science ®Google Scholar
• Ushigome F, Takanaga H, Matsuo H, Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 2000;408:1-10
   PubMed Web of Science ®Google Scholar
• Evseenko DA, Paxton JW, Keelan JA. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 2007;35:595-601
   PubMed Web of Science ®Google Scholar
• Kalabis GM, Petropoulos S, Gibb W, Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone. Placenta 2007;28(10):1073-81
   PubMed Web of Science ®Google Scholar
• Pavek P, Staud F, Fendrich Z, Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J Pharmacol Exp Ther 2003;305(3):1239-50
   PubMed Web of Science ®Google Scholar
• Trezise AE, Romano PR, Gill DR, The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J 1992;11(12):4291-303
   PubMed Web of Science ®Google Scholar
• Novotna M, Libra A, Kopecky M, P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod Toxicol 2004;18(6):785-92
   PubMed Web of Science ®Google Scholar
• Kalabis GM, Kostaki A, Andrews MH, Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod 2005;73(4):591-7
   PubMed Web of Science ®Google Scholar
• Kalabis GM, Petropoulos S, Gibb W, Multidrug resistance phosphoglycoprotein (ABCB1) expression in the guinea pig placenta: developmental changes and regulation by betamethasone. Can J Physiol Pharmacol 2009;87:973-8
   PubMed Web of Science ®Google Scholar
• Smit JW, Huisman MT, van Tellingen O, Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 1999;104:1441-7
   PubMed Web of Science ®Google Scholar
• Pavek P, Fendrich Z, Staud F, Influence of P-glycoprotein on the transplacental passage of cyclosporine. J Pharm Sci 2001;90(10):1583-92
   PubMed Web of Science ®Google Scholar
• Cygalova LH, Hofman J, Ceckova M, Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. J Pharmacol Exp Ther 2009;331:1118-25
   PubMed Web of Science ®Google Scholar
• Molsa M, Heikkinen T, Hakkola J, Functional role of P-glycoprotein in the human blood-placental barrier. Clin Pharmacol Ther 2005;78:123-31
   PubMed Web of Science ®Google Scholar
• Ceccaldi PF, Gavard L, Mandelbrot L, Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model. Obstet Gynecol Int 2009;2009:726593
   PubMedGoogle Scholar
• Nanovskaya T, Nekhayeva I, Karunaratne N, Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol 2005;69:1869-78
   PubMed Web of Science ®Google Scholar
• Hemauer SJ, Nanovskaya TN, Abdel-Rahman SZ, Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Biochem Pharmacol 2010;79:921-5
   PubMed Web of Science ®Google Scholar
• Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol 2010;202:383. e1-7
   PubMed Web of Science ®Google Scholar
• Ushigome F, Takanaga H, Matsuo H, Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 2000;408(1):1-10
   PubMed Web of Science ®Google Scholar
• Sun M, Kingdom J, Baczyk D, Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 2006;27(6-7):602-9
   PubMed Web of Science ®Google Scholar
• Mathias AA, Hitti J, Unadkat JD. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 2005;289:R963-9
   PubMed Web of Science ®Google Scholar
• Gil S, Saura R, Forestier F, P-glycoprotein expression of the human placenta during pregnancy. Placenta 2005;26:268-70
   PubMed Web of Science ®Google Scholar
• Nanovskaya TN, Nekhayeva IA, Hankins GD, Transfer of methadoneacross the dually perfused preterm human placental lobule. Am J Obstet Gynecol 2008;198:126.e1-4
   Google Scholar
• Zhang H, Wu X, Wang H, Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol Pharmacol 2008;74(3):714-23
   PubMed Web of Science ®Google Scholar
• Coles LD, Lee IJ, Hassan HE, Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice. J Pharm Sci 2009;98(8):2832-46
   PubMed Web of Science ®Google Scholar
• Petropoulos S, Kalabis GM, Gibb W, Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone. Reprod Sci 2007;14(4):321-8
   PubMed Web of Science ®Google Scholar
• Wang T, Chen M, Yan YE, Growth retardation of fetal rats exposed to nicotine in utero: possible involvement of CYP1A1, CYP2E1, and P-glycoprotein. Environ Toxicol 2009;24(1):33-42
   PubMed Web of Science ®Google Scholar
• Evseenko DA, Murthi P, Paxton JW, The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J 2007;21:3592-605
   PubMed Web of Science ®Google Scholar
• Aye IL, Paxton JW, Evseenko DA, Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta 2007;28(8-9):868-77
   PubMed Web of Science ®Google Scholar
• Wang H, Wu X, Hudkins K, Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors. Am J Physiol Endocrinol Metab 2006;291(6):E1295-304
   PubMed Web of Science ®Google Scholar
• Jonker JW, Buitelaar M, Wagenaar E, The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 2002;99(24):15649-54
   PubMed Web of Science ®Google Scholar
• Staud F, Vackova Z, Pospechova K, Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther 2006;319(1):53-62
   PubMed Web of Science ®Google Scholar
• Petrovic V, Wang JH, Piquette-Miller M. Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab Dispos 2008;36:1944-50
   PubMed Web of Science ®Google Scholar
• Pollex E, Lubetsky A, Koren G. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta 2008;29:743-7
   PubMed Web of Science ®Google Scholar
• Myllynen P, Kummu M, Kangas T, ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol Appl Pharmacol 2008;232:210-17
   PubMed Web of Science ®Google Scholar
• Immonen E, Kummu M, Petsalo A, Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism. Placenta 2010;31:641-8
   PubMed Web of Science ®Google Scholar
• Jonker JW, Smit JW, Brinkhuis RF, Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 2000;92(20):1651-6
   PubMed Web of Science ®Google Scholar
• Zhou L, Naraharisetti SB, Wang H, The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 2008;73(3):949-59
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang H, Unadkat JD, Mao Q. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab Dispos 2007;35:2154-8
   PubMed Web of Science ®Google Scholar
• Staud F, Vackova Z, Pospechova K, Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J Pharmacol Exp Ther 2006;319:53-62
   PubMed Web of Science ®Google Scholar
• Cygalova L, Ceckova M, Pavek P, Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. Toxicol Lett 2008;178(3):176-80
   PubMed Web of Science ®Google Scholar
• Meyer zu Schwabedissen HE, Grube M, Dreisbach A, Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos 2006;34:524-33
   PubMed Web of Science ®Google Scholar
• Yeboah D, Sun M, Kingdom J, Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 2006;84(12):1251-8
   PubMed Web of Science ®Google Scholar
• Mathias AA, Hitti J, Unadkat JD. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 2005;289:R963-9
   PubMed Web of Science ®Google Scholar
• Yasuda S, Itagaki S, Hirano T, Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 2005;69(10):1871-6
   PubMed Web of Science ®Google Scholar
• Sawicki WT, Kujawa M, Jankowska-Steifer E, Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development. Gene Expr Patterns 2006;6:738-46
   PubMed Web of Science ®Google Scholar
• Elbling L, Berger W, Rehberger A, P-glycoprotein regulates chemosensitivity in early developmental stages of the mouse. FASEB J 1993;7:1499-506
   PubMed Web of Science ®Google Scholar
• Apati A, Orban TI, Varga N, High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim Biophys Acta 2008;1778:2700-9
   PubMed Web of Science ®Google Scholar
• Sarkadi B, Orban TI, Szakacs G, Evaluation of ABCG2 expression in human embryonic stem cells: crossing the same river twice? Stem Cells 2010;28:174-6
   PubMed Web of Science ®Google Scholar
• Krishnamurthy P, Ross DD, Nakanishi T, The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004;279:24218-25
   PubMed Web of Science ®Google Scholar
• Krishnamurthy P, Schuetz JD. The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival. Biometals 2005;18:349-58
   PubMed Web of Science ®Google Scholar
• Andersen HR, Nielsen JB, Grandjean P. Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology 2000;144:121-7
   PubMed Web of Science ®Google Scholar
• Shen S, Zhang W. ABC transporters and drug efflux at the blood–brain barrier. Rev Neurosci 2010;21:29-53
   PubMed Web of Science ®Google Scholar
• Schumacher U, Mollgard K. The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood–brain barrier development in the microvessels of the developing human brain. Histochem Cell Biol 1997;108:179-82
   PubMed Web of Science ®Google Scholar
• Virgintino D, Errede M, Girolamo F, Fetal blood–brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol 2008;67:50-61
   PubMed Web of Science ®Google Scholar
• Daood M, Tsai C, Ahdab-Barmada M, ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 2008;39:211-18
   PubMed Web of Science ®Google Scholar
• van Kalken CK, Giaccone G, van der Valk P, Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol 1992;141:1063-72
   PubMed Web of Science ®Google Scholar
• Ek CJ, Wong A, Liddelow SA, Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol Lett 2010; In press
   Google Scholar
• Rosati A, Maniori S, Decorti G, Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 2003;45:377-87
   PubMed Web of Science ®Google Scholar
• Tsai CE, Daood MJ, Lane RH, P-glycoprotein expression in mouse brain increases with maturation. Biol Neonate 2002;81:58-64
   PubMedGoogle Scholar
• Tachikawa M, Watanabe M, Hori S, Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J Neurochem 2005;95:294-304
   PubMed Web of Science ®Google Scholar
• Schiengold M, Schwantes L, Schwartsmann G, Multidrug resistance gene expression during the murine ontogeny. Mech Ageing Dev 2001;122:255-70
   PubMed Web of Science ®Google Scholar
• Qin Y, Sato TN. Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood–brain barrier development. Dev Dyn 1995;202:172-80
   PubMed Web of Science ®Google Scholar
• Enokizono J, Kusuhara H, Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 2007;72:967-75
   PubMed Web of Science ®Google Scholar
• Clancy B, Finlay BL, Darlington RB, Extrapolating brain development from experimental species to humans. Neurotoxicology 2007;28:931-37
   PubMed Web of Science ®Google Scholar
• Miki Y, Suzuki T, Tazawa C, Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues. Mol Cell Endocrinol 2005;231:75-85
   PubMed Web of Science ®Google Scholar
• Fakhoury M, de Beaumais T, Guimiot F, mRNA expression of MDR1 and major metabolising enzymes in human fetal tissues. Drug Metab Pharmacokinet 2009;24:529-36
   PubMed Web of Science ®Google Scholar
• Mahmood B, Daood MJ, Hart C, Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney. J Investig Med 2001;49:250-57
   PubMed Web of Science ®Google Scholar
• Garrovo C, Rosati A, Bartoli F, St John's wort modulation and developmental expression of multidrug transporters in the rat. Phytother Res 2006;20:468-73
   PubMed Web of Science ®Google Scholar
• Cheng X, Klaassen CD. Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. Drug Metab Dispos 2009;37:2178-85
   PubMed Web of Science ®Google Scholar
• Huls M, Brown CD, Windass AS, The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 2008;73:220-25
   PubMed Web of Science ®Google Scholar
• Pinto N, Halachmi N, Verjee Z, Ontogeny of renal P-glycoprotein expression in mice: correlation with digoxin renal clearance. Pediatr Res 2005;58:1284-89
   PubMed Web of Science ®Google Scholar
• Dutt A, Priebe TS, Teeter LD, Postnatal development of organic cation transport and mdr gene expression in mouse kidney. J Pharmacol Exp Ther 1992;261:1222-30
   PubMed Web of Science ®Google Scholar
• Rawles LA, Acuna D, Erickson RP. The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Mol Reprod Dev 2007;74(11):1483-9
   PubMed Web of Science ®Google Scholar
• Johansson PA, Dziegielewska KM, Liddelow SA, The blood-CSF barrier explained: when development is not immaturity. Bioessays 2008;30:237-48
   PubMed Web of Science ®Google Scholar
• Ala-Kokko TI, Myllynen P, Vahakangas K. Ex vivo perfusion of human placental cotyledon implications for anesthetic pharmacology. Int J Obstet Anesth 2000;9:26-38
   Web of Science ®Google Scholar
• Adamson SL, Lu Y, Whiteley KJ, Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 2002;250:358-73
   PubMed Web of Science ®Google Scholar
• Mylona P, Glazier JD, Greenwood SL, Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. Mol Hum Reprod 1996;2:693-8
   PubMedGoogle Scholar